Morphological changes in the hippocampus following nicotine and kainic acid administration

Physiological Research

Volumn 56, Issue 5, 2007, Pages 641-649

  Riljak, Vladimír ^a   Milotova M ^a   Jandova K ^a   Pokorny J ^a   Langmeier, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Hippocampus; Kainic acid; Neurodegeneration; Nicotine; Nitric oxide

Indexed keywords

AMINO ACID RECEPTOR STIMULATING AGENT; BENZIMIDAZOLE DERIVATIVE; FLUORESCENT DYE; FLUORO JADE; HOE 33342; KAINIC ACID; NICOTINE; NICOTINIC AGENT; ORGANIC COMPOUND; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYMOLOGY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METHODOLOGY; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; RAT; STAINING; WISTAR RAT;

ANIMALS; BENZIMIDAZOLES; EXCITATORY AMINO ACID AGONISTS; FLUORESCENT DYES; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; KAINIC ACID; MALE; NADPH DEHYDROGENASE; NERVE DEGENERATION; NEURONS; NICOTINE; NICOTINIC AGONISTS; ORGANIC CHEMICALS; RATS; RATS, WISTAR; STAINING AND LABELING;

EID: 36849027288     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. BEN ARI Y: Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375-403, 1985.
2. BEN ARI Y, LAGOWSKA J, TREMBLAY E, LE GAL LS: A new model of focal status epilepticus: intra-amygdaloid application of kainic acid elicits repetitive secondarily generalized convulsive seizures. Brain Res 163: 176-179, 1979a.
3. BEN ARI Y, TREMBLAY E, OTTERSEN OP, NAQUET R: Evidence suggesting secondary epileptogenic lesion after kainic acid: pretreatment with diazepam reduces distant but not local brain damage. Brain Res 165: 362-365, 1979b.
4. BENEŠOVÁ P, LANGMEIER M, BETKA J, TROJAN S: Long-lasting changes in the density of nitrergic neurons following kainic acid administration and chronic hypoxia. Physiol Res 54: 565-571, 2005.
5. BENOWITZ NL: Clinical pharmacology of nicotine. Annu Rev Med 37: 21-32, 1986.
6. BORLONGAN CV, SHYTLE RD, ROSS SD, SHIMIZU T, FREEMAN TB, CAHILL DW, SANBERG PR: (-)-nicotine protects against systemic kainic acid-induced excitotoxic effects. Exp Neurol 136: 261-265, 1995.
7. COLUMBANO A: Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 58: 181-190, 1995.
8. CORMIER A, MORIN C, ZINI R, TILLEMENT JP, LAGRUE G: Nicotine protects rat brain mitochondria against experimental injuries. Neuropharmacology 44: 642-652, 2003.
9. DE MONTIGNY C, TARDIF D: Differential excitatory effects of kainic acid on CA3 and CA1 hippocampal pyramidal neurons: further evidence for the excitotoxic hypothesis and for a receptor-mediated action. Life Sci 29: 2103-2111, 1981.
10. FRENCH ED, ALDINIO C, SCHWARCZ R: Intrahippocampal kainic acid, seizures and local neuronal degeneration: relationships assessed in unanesthetized rats. Neuroscience 7: 2525-2536, 1982.
11. GOTTESFELD Z, JACOBOWITZ DM: Kainic acid-induced neurotoxicity in the striatum: a histofluorescent study. Brain Res 169: 513-518, 1979.
12. IADECOLA C: Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link? Trends Neurosci 16: 206-214, 1993.
13. ISCHIROPOULOS H, ZHU L, CHEN J, TSAI M, MARTIN JC, SMITH CD, BECKMAN JS: Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 298: 431-437, 1992.
14. JAMES JR, NORDBERG A: Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behav Genet 25: 149-159, 1995.
15. JANDOVÁ K, LANGMEIER M, MAREŠOVÁ D, POKORNÝ J, TROJAN S: Effect of magnesium pre-treatment on the hippocampal NOS activity during long-lasting intermittent hypoxia. Prague Med Rep 107: 108-116, 2006.
16. JOHNSON EM, DECKWERTH TL: Molecular mechanism of developmental neuronal death. Annu Rev Neurosci 16: 31-46, 1993.
17. KISS JP: Role of nitric oxide in the regulation of monoaminergic neurotransmission. Brain Res Bull 52: 459-466, 2000.
18. KOH JY, PETERS S, CHOI DW: Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. Science 234: 73-76, 1986.
19. KOHLER C, SCHWARCZ R, FUXE K: Hippocampal lesions indicate differences between the excitotoxic properties of acidic amino acids. Brain Res 175: 366-371, 1979.
20. KORYNTOVÁ H, ŠLAPAL R, LANGMEIER M, HAUGVICOVÁ R, MAREŠ P: Effects of a subconvulsant dose of kainic acid on afterdischarges elicited by cortical stimulation in rats. Epilepsy Res 29: 25-33, 1997.
21. LERNER-NATOLI M, DE BOCK F, BOCKAERT J, RONDOUIN G: NADPH diaphorase-positive cells in the brain after status epilepticus. Neuroreport 5: 2633-2637, 1994.
22. MAREŠOVÁ D, JANDOVÁ K, BORTELOVÁ J, TROJAN S, TRNKOVÁ B: Functional and morphological changes of the brain in rats exposed to intermittent hypobaric hypoxia after the repetitive magnesium administration. Prague Med Rep 106: 61-69, 2005.
23. MATARREDONA ER, SANTIAGO M, VENERO JL, CANO J, MACHADO A: Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction. J Neurochem 76: 351-360, 2001.
24. MILOTOVÁ M, RILJAK V, LANGMEIER M, MAREŠOVÁ D, JANDOVÁ K, POKORNÝ J, TROJAN S: Effect of the perinatal alcohol abuse on the development of neuronal population in the hippocampus. Prague Med Rep 106: 71-74, 2005.
25. NADLER JV, PERRY BW, GENTRY C, COTMAN CW: Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid. J Comp Neurol 192: 333-359, 1980.
26. NEWMAN MB, ARENDASH GW, SHYTLE RD, BICKFORD PC, TIGHE T, SANBERG PR: Nicotine's oxidative and antioxidant properties in CNS. Life Sci 71: 2807-2820, 2002.
27. NICOTERA R, LIPTON SA: Excitotoxins in neuronal apoptosis and necrosis. J Cereb Blood Flow Metab 19: 583-591, 1999.
28. OBATA T, AOMINE M, INADA T, KINEMUCHI H: Nicotine suppresses 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in rat striatum. Neurosci Lett 330: 122-124, 2002.
29. PRAST H, PHILIPPU A: Nitric oxide as modulator of neuronal function. Prog Neurobiol 64: 51-68, 2001.
30. RIGAUD-MONNET AS, HERON A, SEYLAZ J, PINARD E: Effect of inhibiting NO synthesis on hippocampal extracellular glutamate concentration in seizures induced by kainic acid. Brain Res 673: 297-303, 1995.
31. RIGAUD-MONNET AS, PINARD E, BORREDON J, SEYLAZ J: Blockade of nitric oxide synthesis inhibits hippocampal hyperemia in kainic acid-induced seizures. J Cereb Blood Flow Metab 14: 581-590, 1994.
32. RILJAK V, MILOTOVÁ M, JANDOVÁ K, LANGMEIER M, MAREŠOVÁ D, POKORNÝ J, TROJAN S: Repeated kainic acid administration and hippocampal neuronal degeneration. Prague Med Rep 106: 75-78, 2005.
33. RILJAK V, MILOTOVÁ M, JANDOVÁ K, MAREŠOVÁ D, POKORNÝ J, TROJAN S, LANGMEIER M: Changes in the number of nitrergic neurons in rats hippocampus following nicotine administration. Prague Med Rep 107: 117-124, 2006.
34. ROCERI M, MOLTENI R, FUMAGALLI F, RACAGNI G, GENNARELLI M, CORSINI G, MAGGIO R, RIVA M: Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum. J Neurochem 76: 990-997, 2001.
35. RYAN RE, ROSS SA, DRAGO J, LOIACONO RE: Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br J Pharmacol 132: 1650-1656, 2001.
36. SAWADA S, HIGASHIMA M, YAMAMOTO C: Kainic acid induces long-lasting depolarizations in hippocampal neurons only when applied to stratum lucidum. Exp Brain Res 72: 135-140, 1988.
37. SCHMUED LC, HOPKINS KJ: Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874: 123-130, 2000.
38. SEMBA J, MIYOSHI R, KITO S: Nicotine protects against the dexamethasone potentiation of kainic acid-induced neurotoxicity in cultured hippocampal neurons. Brain Res 735: 335-338, 1996.
39. SHYTLE RD, BORLONGAN CV, SANBERG PR: Nicotine blocks kainic acid-induced wet dog shakes in rats. Neuropsychopharmacol 13: 261-264, 1995.
40. SOTO-OTERO R, MENDEZ-ALVAREZ E, HERMIDA-AMEIJEIRAS A, LOPEZ-REAL AM, LABANDEIRA-GARCIA JL: Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease. Biochem Pharmacol 64: 125-135, 2002.
41. SPERK G: Kainic acid seizures in the rat. Prog Neurobiol 42: 1-32, 1994.
42. SPERK G, LASSMANN H, BARAN H, KISH SJ, SEITELBERGER F, HORNYKIEWICZ O: Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10: 1301-1315, 1983.
43. TURNER DA, WHEAL HV: Excitatory synaptic potentials in kainic acid-denervated rat CA1 pyramidal neurons. J Neurosci 11: 2786-2794, 1991.
44. WANG TJ, LUE JH, SHIEH JY, WEN CY: The distribution and characterization of NADPH-d/NOS-IR neurons in the rat cuneate nucleus. Brain Res 910: 38-48, 2001.
45. YOSHIHARA Y, ONODERA H, IINUMA K, ITOYAMA Y: Abnormal kainic acid receptor density and reduced seizure susceptibility in dystrophin-deficient mdx mice. Neuroscience 117: 391-395, 2003.